Short pulse gastric electrical stimulation for cisplatin-induced emesis in dogs

Neurogastroenterology and Motility

Volumn 23, Issue 5, 2011, Pages

  Song, J ^a   Zhong, D X ^a   Qian, W ^a   Hou, X H ^a   Chen, J D Z ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Chemotherapy; Gastric electrical stimulation; Gastrointestinal motility; Nausea and vomiting; Slow waves

Indexed keywords

CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; ELECTROSTIMULATION; GASTROINTESTINAL MOTILITY; NAUSEA; NONHUMAN; PRIORITY JOURNAL; VOMITING;

ANIMALS; ANTINEOPLASTIC AGENTS; BEHAVIOR, ANIMAL; CISPLATIN; DOGS; ELECTRIC STIMULATION; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEMALE; GASTROINTESTINAL MOTILITY; NAUSEA; STOMACH; VOMITING;

EID: 79954420454     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2011.01684.x     Document Type: Article

References (52)

1. Blackhall FH, O'brien M, Schmid P et al. A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer. J Thorac Oncol 2010; 5: 1285-8.
2. Movsas B, Langer CJ, Ross HJ et al. Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer. J Thorac Oncol 2010; 5: 673-9.
3. Sarosy GA, Hussain MM, Seiden MV et al. Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer. Cancer 2010; 116: 1476-84.
4. Koshy N, Quispe D, Shi R, Mansour R, Burton GV. Cisplatin-gemcitabine therapy in metastatic breast cancer: improved outcome in triple negative breast cancer patients compared to non-triple negative patients. Breast 2010; 19: 246-8.
5. Yoshikawa T, Omura K, Kobayashi O et al. A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study). Eur J Surg Oncol 2010; 36: 546-51.
6. Yoon DH, Kim SB. S-1 plus cisplatin: another option in the treatment of advanced head and neck cancer? Expert Rev Anticancer Ther 2010; 10: 659-62.
7. Landry J, Catalano PJ, Staley C et al. Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma. J Surg Oncol 2010; 101: 587-92.
8. Møller AK, Pedersen KD, Gothelf A, Daugaard G. Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study. Acta Oncol 2010; 49: 423-30.
9. Egerer G, Hegenbart U, Salwender HJ, Goldschmidt H, Ho AD. Treatment of chemotherapy-induced emesis. Antibiot Chemother 2000; 50: 171-83.
10. Jordan K, Kasper C, Schmoll HJ. Chemotherapy- induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment. Eur J Cancer 2005; 41: 199-205.
11. Gore L, Chawla S, Petrilli A et al. Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo- controlled study of efficacy and tolerability. Pediatr Blood Cancer 2009; 52: 242-7.
12. Grunberg SM, Dugan M, Muss H et al. Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy. Support Care Cancer 2009; 17: 589-94.
13. Cefalo MG, Ruggiero A, Maurizi P, Attinà G, Arlotta A, Riccardi R. Pharmacological management of chemotherapy-induced nausea and vomiting in children with cancer. J Chemother 2009; 21: 605-10.
14. Herrstedt J, Dombernowsky P. Anti-emetic therapy in cancer chemotherapy: current status. Basic Clin Pharmacol Toxicol 2007; 101: 143-50.
15. Khan NU, Razzak JA. Abdominal pain with rigidity secondary to the anti-emetic drug metoclopramide. J Emerg Med 2006; 30: 411-3.
16. Ritter MJ, Goodman BP, Sprung J, Wijdicks EF. Ondansetron-induced multifocal encephalopathy. Mayo Clin Proc 2003; 78: 1150-2.
17. McCallum RW, Chen JD, Lin Z, Schirmer BD, Williams RD, Ross RA. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology 1998; 114: 456-61.
18. Abell T, McCallum R, Hocking M et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003; 125: 421-8.
19. Zhang J, Tang M, Chen JD. Gastric electrical stimulation for obesity: the need for a new device using wider pulses. Obesity (Silver Spring) 2009; 17: 474-80.
20. Shikora SA. Implantable gastric stimulation for the treatment of severe obestiy. Obes Surg 2004; 14: 545-8.
21. Musunuru S, Beverstein G, Gould J. Preoperative predictors of significant symptomatic response after 1year of gastric electrical stimulation for gastroparesis. World J Surg 2010; 34: 1853-8.
22. O'Grady G, Egbuji JU, Du P, Cheng LK, Pullan AJ, Windsor JA. High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis. World J Surg 2009; 33: 1693-701.
23. Lin Z, Hou Q, Sarosiek I, Forster J, McCallum RW. Association between changes in symptoms and gastric emptying in gastroparetic patients treated with gastric electrical stimulation. Neurogastroenterol Motil 2008; 20: 464-70.
24. McKenna D, Beverstein G, Reichelderfer M, Gaumnitz E, Gould J. Gastric electrical stimulation is an effective and safe treatment for medically refractory gastroparesis. Surgery 2008; 144: 566-72.
25. Maranki JL, Lytes V, Meilahn JE et al. Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis. Dig Dis Sci 2008; 53: 2072-8.
26. van der Voort IR, Becker JC, Dietl KH, Konturek JW, Domschke W, Pohle T. Gastric electrical stimulation results in improved metabolic control in diabetic patients suffering from gastroparesis. Exp Clin Endocrinol Diabetes 2005; 113: 38-42.
27. Lin Z, Sarosiek I, Forster J, McCallum RW. Symptom responses, long-term outcomes and adverse events beyond 3years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol Motil 2006; 18: 18-27.
28. Lin Z, Forster J, Sarosiek I, McCallum RW. Treatment of diabetic gastroparesis by high-frequency gastric electricalstimulation. Diabetes Care 2004; 27: 1071-6.
29. Yu X, Yang J, Hou X, Zhang K, Qian W, Chen JD. Cisplatin-induced gastric dysrhythmia and emesis in dogs and possible role of gastric electrical stimulation. Dig Dis Sci 2009; 54: 922-7.
30. Lei Y, Xing J, Chen J. The effect on gastric tone of gastric electrical stimulation with trains of short pulses varies with sites and stimulation conditions. Dig Dis Sci 2008; 53: 2066-71.
31. Hou X, Song GQ, Yang B, Sun Y, Qian W, Chen JD. Effects of gastric electrical stimulation with short pulses and long pulses on gastric dysrhythmia and signs induced by vasopressin in dogs. Dig Dis Sci 2008; 53: 630-5.
32. Lei Y, Xing J, Chen JD. Effects and mechanisms of implantable gastric stimulation on gastric distention in conscious dogs. Obes Surg 2005; 15: 528-33.
33. Han JS. Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci 2003; 26: 17-22.
34. Chen JDZ, Qian LW, Ouyang H, Yin JY. Gastric electrical stimulation with short pulses improves vomiting but not gastric dysrhythmia in dogs. Gastroenterology 2003; 124: 401-9.
35. Xu X, Brining DL, Chen JD. Effects of vasopressin and long pulse-low frequency gastric electrical stimulation on gastric emptying, gastric and intestinal myoelectric activity and symptoms in dogs. Neurogastroenterol Motil 2005; 17: 236-44.
36. Van Belle S, Lichinitser MR, Navari RM et al. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758, 298 and MK-869. Cancer 2002; 94: 3032-41.
37. Ogilvie GK, Fettman MJ, Jameson VJ et al. Evaluation of a one-hour saline diuresis protocol for administration of cisplatin to dogs. Am J Vet Res 1992; 53: 1666-9.
38. Chey RD, Lee KY, Asbury R, Chey WY. Effect of cisplatin on myoelectric activity of the stomach and small intestine in dogs. Dig Dis Sci 1988; 33: 338-44.
39. Song G, Hou X, Yang B et al. Efficacy and efficiency of gastric electrical stimulation with short pulses in the treatment of vasopressin-induced emetic responses in dogs. Neurogastroenterol Motil 2006; 18: 385-91.
40. Liu J, Qiao X, Chen JD. Therapeutic potentials of a novel method of dual-pulse gastric electrical stimulation for gastric dysrhythmia and symptoms of nausea and vomiting. Am J Surg 2006; 191: 255-61.
41. Hasler WL. Methods of gastric electrical stimulation and pacing: a review of their benefits and mechanisms of action in gastroparesis and obesity. Neurogastroenterol Motil 2009; 21: 229-43.
42. Xu X, Lei Y, Chen JD. Effects and mechanisms of electrical stimulation of the stomach, duodenum, ileum, and colon on gastric tone in dogs. Dig Dis Sci 2010; 55: 895-901.
43. McCallum RW, Dusing RW, Sarosiek I, Cocjin J, Forster J, Lin Z. Mechanisms of high-frequency electrical stimulation of the stomach in gastroparetic patients. Conf Proc IEEE Eng Med Biol Soc 2006; 1: 5400-3.
44. Frøkjaer JB, Ejskjaer N, Rask P et al. Central neuronal mechanisms of gastric electrical stimulation in diabetic gastroparesis. Scand J Gastroenterol 2008; 43: 1066-75.
45. Gourcerol G, Gallas S, Mounien L et al. Gastric electrical stimulation modulates hypothalamic corticotropin-releasing factor producing neurons during post-operative ileus in rat. Neuroscience 2007; 148: 775-81.
46. McCallum RW, Dusing RW, Sarosiek I, Cocjin J, Forster J, Lin Z. Mechanisms of symptomatic improvement after gastric electrical stimulation in gastroparetic patients. Neurogastroenterol Motil 2010; 22: 161-7. e50-1.
47. Chen JH, Song GQ, Yin J, Sun Y, Chen JD. Gastric electrical stimulation reduces visceral sensitivity to gastric distention in healthy canines. Auton Neurosci 2011; 160: 16-20.
48. Song GQ, Lei Y, Xu X, Chen JD. Gastric electrical stimulation with long pulses in humans and animals: can data obtained in animals be replicated in humans? Neuromodulation 2010; 13: 87-92.
49. Ayinala S, Batista O, Goyal A et al. Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis. Gastrointest Endosc 2005; 61: 455-61.
50. Xu X, Pasricha PJ, Chen JD. Feasibility of gastric electrical stimulation by use of endoscopically placed electrodes. Gastrointest Endosc 2007; 66: 981-6.
51. Andersson S, Ringström G, Elfvin A, Simrén M, Lönroth H, Abrahamsson H. Temporary percutaneous gastric electrical stimulation: a novel technique tested in patients with non-established indications for gastric electrical stimulation. Digestion 2011; 83: 3-12.
52. Liu J, Hou X, Song G, Cha H, Yang B, Chen JD. Gastric electrical stimulation using endoscopically placed mucosal electrodes reduces food intake in humans. Am J Gastroenterol 2006; 101: 798-803.